Larimar Therapeutics president, COO John B. Harlow Jr. files initial beneficial ownership statement
LRMR•Larimar Therapeutics filed an initial Form 3 for President and COO John B. Harlow Jr., dated Sept. 29, 2026.
1. Initial filing
Larimar Therapeutics filed an initial Form 3 for President and COO John B. Harlow Jr., dated Sept. 29, 2026.
